首页 正文

APP下载

南昌市那治躁狂症好(南昌治精神疾病的医院在哪) (今日更新中)

看点
2025-05-23 21:59:14
去App听语音播报
打开APP
  

南昌市那治躁狂症好-【南昌市第十二医院精神科】,南昌市第十二医院精神科,南昌治焦虑症中医医院,精神失常症南昌哪里治,南昌哪里医院可以看癫痫,南昌治幻视的医院哪里好,南昌第十二医院技术怎样,南昌治精神心理很好的医院

  南昌市那治躁狂症好   

BEIJING, March 3 (Xinhuanet) -- A new study suggested that regular use of painkiller ibuprofen may cut the risk of developing Parkinson's disease, according to Reuters reports.The research findings were published in the online edition of the journal Neurology on Wednesday and later will appear in the print edition on March 8.The study, which followed more than 136,000 U.S. men and women for six years, showed that people who took ibuprofen at least twice a week were 38 percent less likely to develop Parkinson's, a brain disorder that causes tremors and movement problems, compared to those who didn't take the pain reliever so often.Ibuprofen is sold in the U.S. as a non-steroidal anti-inflammatory drug (NSAID). But the study didn't prove that other NSAIDS, like aspirin or naproxen, could also cut the Parkinson's risk."Our study suggests ibuprofen could be a potential neuroprotective agent against Parkinson's," says lead researcher Dr. Xiang Gao from Harvard Medical School, "Protective effects are seen after taking ibuprofen two or more times a week. That's so-called regular use."However, he also warned that no proof has been found that ibuprofen itself can help ward off Parkinson's, and said that it's too early to recommend people to start taking ibuprofen to protect against the disorder.Gao said, "We just see an association, not some causal relationship."Besides, regular ibuprofen use has risks, like stomach bleeding and kidney damage.

  南昌市那治躁狂症好   

BEIJING, Feb. 1 (Xinhua) -- Senior Chinese official Zhou Yongkang Tuesday called on law enforcement personnel to take more preventive measures against crime and accidents during the Lunar New Year holiday.Zhou, a Standing Committee member of the Political Bureau of the Communist Party of China (CPC) Central Committee, visited community security personnel, a district court, and police patrolling downtown Beijing Tuesday.He also visited a police station that is responsible for keeping public order in the area surrounding the central leadership compound of Zhongnanhai.During his visits, Zhou, who also heads the Commission for Political and Legal Affairs of the CPC Central Committee, said China was seeing the travel peak for the Spring Festival and some regions were suffering icy weather and lingering drought.He asked the police to take effective measures in traffic control and fire-fighting work, and maintain social order during the holiday season.He commended the practice of deploying special police to patrol the surrounding areas of the Tiananmen Square in central Beijing, saying it could deter crime and enable quick responses to emergencies.During his visit to the district court, Zhou warned there were still "many social conflicts."He asked local courts to solve social conflicts more effectively, promote innovative social management and law enforcement in a just and clean manner.The Spring Festival, or Chinese lunar New Year, is the most important festival for Chinese. It falls on Feb. 3 this year.

  南昌市那治躁狂症好   

SAN FRANCISCO, April 7 (Xinhua) -- Google's Android will become the most popular smartphone operating system worldwide and will account for 49 percent of the market by 2012, IT research and advisory firm Gartner said Thursday.According to Gartner's projections, worldwide smartphone sales will reach 468 million units in 2011, a 57.7 percent increase from 2010.The company predicts that Apple's iOS will remain the second biggest platform worldwide through 2014 although its share will decrease slightly after 2011, on the assumption that "Apple will be interested in maintaining margins rather than pursuing market share by changing its pricing strategy."Microsoft's Windows, driven by its partnership with Nokia, is expected to move into the mid-tier by the end of 2012 and become the third largest in the worldwide ranking by 2013.Some analysts raised doubts on Gartner's forecasts, saying that its assumption on Apple's price strategy contradicts statements by Apple's chief operating officer Tim Cook and the cooperation between Nokia and Microsoft will not have that much of an impact on smartphone market share by 2012.

  

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.

  

BEIJING, Feb. 13 (Xinhua) -- Chinese State Councilor Meng Jianzhu left here Sunday for visits to the Democratic People's Republic of Korea (DPRK), Laos, Singapore and Malaysia.Meng, who is also Chinese Minister of Public Security, is traveling to the countries at the invitation of the DPRK Minister of People's Security Ju Sang Song, Lao Minister of Public Security Thongbanh Seng-aphone, Singaporean Minister for Home Affairs and Minister of Law K Shanmugam, and Malaysian Minister of Home Affairs Hishiammuddin Tun Hussein.

来源:资阳报

分享文章到
说说你的看法...
A-
A+
热门新闻

南昌治疗精神心理医院哪里的好

南昌心理咨询室治疗焦虑

南昌疑心到那里治疗好

南昌哪家医院治神经病医院

南昌市第十二医院精神科医院好么靠谱么

南昌抑郁能治么

南昌的脑科医院

南昌治焦虑最专业的中医院

南昌失眠症要看哪个科

南昌治疗精神障碍症那个医院比较好

南昌市第十二医院QQ咨询

南昌治躁狂去那个医院

南昌发狂怎样治疗

南昌市第十二医院精神科医院技术靠谱不

南昌重度抑郁哪里可以治疗

南昌治幻想哪个医院好一点

南昌治疗疑心医院在哪里

南昌恐惧症治疗医院那家好

南昌那个医院可以治疗幻觉

南昌哪个的植物神经紊乱好

南昌哪里治疗老年抑郁

南昌抑郁有哪些治疗方式

南昌精神病院怎么治疗精神病

南昌看抑郁哪家好

南昌治疗神经衰弱医院哪好

南昌治幻想那家医院好一点